Finance

Beta
Lists
HSTM:NASDAQ
HealthStream Inc
$27.25
+0.44%
(+0.12) 1D
$27.25
0.00% (0.00)
After hours
Closed: Jun 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HSTM...
Open
$27.17
High
$27.92
Low
$26.50
Mkt. cap
796.11M
Avg. vol.
246.94K
Volume
186.75K
Dividend
0.51%
Quarterly dividend
$0.03
Ex-dividend date
May 18, 2026
P/E ratio
40.84
52-wk high
$29.59
52-wk low
$19.50
EPS
$0.67
Beta
0.47
Shares outstanding
29.22M
No. of employees
1K
Open
$27.17
High
$27.92
Low
$26.50
Mkt. cap
796.11M
Avg. vol.
246.94K
Volume
186.75K
Dividend
0.51%
Quarterly dividend
$0.03
Ex-dividend date
May 18, 2026
P/E ratio
40.84
52-wk high
$29.59
52-wk low
$19.50
EPS
$0.67
Beta
0.47
Shares outstanding
29.22M
No. of employees
1K
News stories
From sources across the web
About HealthStream Inc
CEORobert A. Frist Jr.
Employees1.15K
Founded1990
HeadquartersNashville, Tennessee, United States
SectorHealth care
Websitehealthstream.com
Analyst ratings
Based on 4 analysts giving stock ratings to HSTM in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for HSTM in the last 3 months.
Highest
Current $27.25
$40.00 (+46.79%)
Average
$32.00 (+17.43%)
Lowest
$24.00 (-11.93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vincent Colicchio
Barrington
Hold
Maintained
-
-
05/18/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
05/13/2026
Matt Hewitt
Craig-Hallum
Buy
Reiterated
$40.00
+46.8%
05/06/2026
Richard Close
Canaccord Genuity
Hold
Reiterated
$24.00
-11.9%
05/06/2026
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.20 / $0.17
+17.65%beat
Revenue / Est. (USD)
81.20M / 79.68M
+1.91%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
74.40M
76.47M
79.71M
81.20M
Cost of goods sold
26.36M
26.51M
28.85M
27.76M
Cost of revenue
26.36M
26.51M
28.85M
27.76M
Research and development expenses
12.07M
12.11M
14.76M
13.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.21M
19.47M
22.16M
20.96M
Operating expense
42.15M
42.40M
47.95M
45.93M
Total operating expenses
68.51M
68.91M
76.80M
73.69M
Operating income
5.89M
7.57M
2.90M
7.51M
Other non operating income
-
-77.00K
-2.00K
-81.00K
EBT including unusual items
6.87M
8.25M
2.85M
7.82M
EBT excluding unusual items
6.87M
8.25M
3.35M
7.82M
Income tax expense
1.48M
2.17M
317.00K
1.91M
Effective tax rate
21.52%
26.25%
11.12%
24.42%
Other operating expenses
-
-
-
-
Net income
5.39M
6.09M
2.53M
5.91M
Net profit margin
7.24%
7.96%
3.18%
7.28%
Earnings per share
0.18
0.20
0.18
0.20
Interest and investment income
958.00K
788.00K
664.00K
414.00K
Interest expense
-
-26.00K
-25.00K
-25.00K
Net interest expenses
958.00K
762.00K
639.00K
389.00K
Depreciation and amortization charges
10.87M
10.82M
11.04M
11.36M
EBITDA
16.75M
18.39M
13.94M
18.88M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer